focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,160.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 140.00 (3.365%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,160.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

18 Jun 2013 15:01

RNS Number : 3195H
North Atlantic Smlr Co Inv Tst PLC
18 June 2013
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD ENDED 31 MAY 2013

 

To the members of North Atlantic Smaller Companies Investment Trust PLC

This interim management statement has been produced solely to provide additional information to shareholders as a body in accordance with the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 February 2013 to 31 May 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Financial Highlights

Cumulative performance

As at

31 May 2013

3 months %

6 months %

1 year %

3 years %

5 years %

Diluted NAV*

1,749p

1.6

8.7

22.7

43.5

50.0

Mid-market price

1,440p 

3.3

17.6

55.7

70.8

41.9

Discount to diluted NAV *

17.7% 

Standard & Poor's 500 Composite Index **

1,073.0

7.4

21.3

26.2

43.2

51.9

Russell 2000 **

647.5

7.8

26.1

30.1

42.3

91.9

FTSE All-Share Index

5,090.8

5.0

15.3

30.1

44.1

35.2

US Dollar/Sterling exchange rate

1.5161

0.1

5.4

1.5

(4.4)

23.5

 

* Following the conversion of the Loan Stock, the performance is shown on the diluted NAV (excluding retained revenue for the period) only. The Board considers that this accurately reflects the underlying performance of the Company.

** Sterling adjusted.

 

 

Material Events and Transactions during the Period

 

During the period under review, the Company's Convertible Unsecured Loan Stock 2013 ("the Loan Stock") was all either converted voluntarily by the Loan Stockholders themselves, or was then compulsorily converted by the Trustee of the Loan Stock and subsequently sold with the proceeds from that sale then being distributed rateably to Stockholders. Following this, the Company no longer has any Loan Stock.

 

There have been no material transactions during the quarter ended 31 May 2013.

 

Transaction in Own Shares

 

There have been no transactions in the Company's own shares during the quarter ended 31 May 2013.

 

 

TEN LARGEST INVESTMENTS AT 31 MAY 2013 Percentage of Portfolio

Gleeson (MJ) Group

UK Listed

11.0

US Treasury Bills

US Treasury Bills

10.5

Oryx International Growth Fund Limited *

UK Listed

9.6

Bionostics Holdings Limited

US Unquoted

8.8

Trident Private Equity Fund III LLP

UK Unquoted

7.8

Hampton Investment Properties Limited

UK Unquoted

5.1

Celsis AG

US Unquoted

4.7

Bioquell

UK Listed

3.4

Guinness Peat Group **

UK Listed

3.4

AssetCo PLC

UK Listed

3.3

% of total portfolio

67.6

 

* incorporated in Guernsey

** incorporated in New Zealand

 

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 MAY 2013

 

United 

United 

Total 

States 

Kingdom 

Europe 

Investment Companies

10.1

9.6

19.7

Health Care, Equipment & Services

0.2

11.1

11.3

Construction & Materials

11.0

11.0

Treasury Bills

10.5

10.5

Manufacturing

8.8

8.8

Real Estate

7.5

0.4

7.9

General Financials

4.3

4.3

Support Services

1.3

2.6

3.9

Financial Services

3.4

3.4

Industrial Engineering

3.3

3.3

General Industrials

1.2

1.5

2.7

General Retailers

2.7

2.7

Transportation

2.6

2.6

Media

0.5

1.8

2.3

Travel & Leisure

2.1

2.1

Oil & Gas Producers

1.1

0.8

1.9

Technology Hardware & Equipment

1.6

1.6

 

The financial information for the period ended 31 May 2013 contained within this Interim Management Statement has not been audited.

 

By order of the Board

 

 

Bonita Guntrip

Company Secretary

18 June 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKMGMVFRLGFZM
Date   Source Headline
16th Sep 20204:11 pmRNSHalf-year Report
1st Sep 202012:50 pmRNSNet Asset Value(s)
19th Aug 202012:48 pmRNSNet Asset Value(s)
24th Jul 20204:08 pmRNSHolding(s) in Company
23rd Jul 202011:43 amRNSHolding(s) in Company
21st Jul 20204:33 pmRNSNet Asset Value(s)
17th Jul 202012:19 pmRNSHolding(s) in Company
14th Jul 20201:02 pmRNSInvestor Meeting
3rd Jul 20206:00 pmRNSDirector/PDMR Shareholding
2nd Jul 202011:07 amRNSHolding(s) in Company
2nd Jul 20209:55 amRNSHolding(s) in Company
23rd Jun 20201:09 pmRNSAGM Statement
18th Jun 202011:58 amRNSNet Asset Value(s)
11th Jun 20203:59 pmRNSNotice of AGM
1st Jun 20203:43 pmRNSDirector/PDMR Shareholding
26th May 202011:39 amRNSNet Asset Value(s)
22nd May 20204:52 pmRNSAnnual Financial Report
22nd May 202011:10 amRNSHolding(s) in Company
12th May 20205:14 pmRNSFinal Results
29th Apr 202010:44 amRNSNet Asset Value(s)
25th Mar 20203:26 pmRNSDirector/PDMR Shareholding
19th Mar 202011:49 amRNSNet Asset Value(s)
13th Mar 20204:42 pmRNSSecond Price Monitoring Extn
13th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Mar 20203:57 pmRNSHolding(s) in Company
28th Feb 20204:37 pmRNSPrice Monitoring Extension
18th Feb 20203:19 pmRNSHoldings in Company
17th Feb 202012:39 pmRNSNet Asset Value(s)
22nd Jan 20205:07 pmRNSNet Asset Value(s)
17th Jan 20204:05 pmRNSHolding(s) in Company
23rd Dec 201910:54 amRNSHolding(s) in Company
20th Dec 20195:28 pmRNSTransaction in Own Shares
17th Dec 201910:44 amRNSHolding(s) in Company
17th Dec 201910:39 amRNSHolding(s) in Company
13th Dec 201912:12 pmRNSNet Asset Value(s)
22nd Nov 20191:58 pmRNSHolding(s) in Company
22nd Nov 20191:02 pmRNSDirector/PDMR Shareholding
22nd Nov 20191:00 pmRNSDirector/PDMR Shareholding
21st Nov 20194:04 pmRNSDirector/PDMR Shareholding
19th Nov 201910:55 amRNSNet Asset Value(s)
15th Nov 20193:13 pmRNSHolding(s) in Company
14th Nov 20195:24 pmRNSHolding(s) in Company
22nd Oct 201910:49 amRNSNet Asset Value(s)
9th Oct 20193:55 pmRNSDividend Declaration
16th Sep 20194:17 pmRNSHalf-year Report
13th Sep 201910:40 amRNSNet Asset Value(s)
21st Aug 201911:18 amRNSNet Asset Value(s)
5th Aug 20195:27 pmRNSTransaction in Own Shares
24th Jul 20195:02 pmRNSHolding(s) in Company
15th Jul 20197:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.